Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 First FDA Nod for Moon Surgical's Maestro Surgical Robot - Medical Product Outsourcing
OEM News

First FDA Nod for Moon Surgical’s Maestro Surgical Robot

Maestro aims to support the 18.8 million annual soft tissue surgical procedures not currently supported by telerobotic systems.

French-American pioneer in accessible surgical innovation Moon Surgical has obtained U.S. Food and Drug Administration (FDA) clearance for its Maestro surgical robotics system.
 
Maestro aims to support the 18.8 million annual soft tissue surgical procedures not currently supported by telerobotic systems on the market. The robot is small, adaptable, and can be integrated into existing workflows, according to the company.
 
The system’s capabilities can bolster operating room efficiency and permit alternative labor models.
 
“We have seen tremendous interest from surgical practices in the U.S. and are eager to see surgeons and their staff using Maestro for the benefit of their patients in that geography,” Professor Brice Gayet, a visionary laparoscopist and co-founder of Moon Surgical, told the press. “Maestro will dramatically change the way in which the standard of care is performed in soft tissue surgery, for millions of patients each year.”
 
Moon System at this moment is finalizing development of its first commercial system.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters

Topics